These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 32636844)

  • 1. Fifteen Years of Sm-p80-Based Vaccine Trials in Nonhuman Primates: Antibodies From Vaccinated Baboons Confer Protection
    Zhang W; Le L; Ahmad G; Molehin AJ; Siddiqui AJ; Torben W; Karmakar S; Rojo JU; Sennoune S; Lazarus S; Khatoon S; Freeborn J; Sudduth J; Rezk AF; Carey D; Wolf RF; Papin JF; Damian R; Gray SA; Marks F; Carter D; Siddiqui AA
    Front Immunol; 2020; 11():1246. PubMed ID: 32636844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cross-species protection: Schistosoma mansoni Sm-p80 vaccine confers protection against Schistosoma haematobium in hamsters and baboons.
    Karmakar S; Zhang W; Ahmad G; Torben W; Alam MU; Le L; Damian RT; Wolf RF; White GL; Carey DW; Carter D; Reed SG; Siddiqui AA
    Vaccine; 2014 Mar; 32(11):1296-303. PubMed ID: 24397898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of antibodies in Sm-p80-mediated protection against Schistosoma mansoni challenge infection in murine and nonhuman primate models.
    Torben W; Ahmad G; Zhang W; Siddiqui AA
    Vaccine; 2011 Mar; 29(12):2262-71. PubMed ID: 21277404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross-species prophylactic efficacy of Sm-p80-based vaccine and intracellular localization of Sm-p80/Sm-p80 ortholog proteins during development in Schistosoma mansoni, Schistosoma japonicum, and Schistosoma haematobium.
    Molehin AJ; Sennoune SR; Zhang W; Rojo JU; Siddiqui AJ; Herrera KA; Johnson L; Sudduth J; May J; Siddiqui AA
    Parasitol Res; 2017 Nov; 116(11):3175-3188. PubMed ID: 29026995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of an Sm-p80-based therapeutic vaccine to kill established adult schistosome parasites in chronically infected baboons.
    Karmakar S; Zhang W; Ahmad G; Torben W; Alam MU; Le L; Damian RT; Wolf RF; White GL; Carey DW; Carter D; Reed SG; Siddiqui AA
    J Infect Dis; 2014 Jun; 209(12):1929-40. PubMed ID: 24436452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sm-p80-based vaccine trial in baboons: efficacy when mimicking natural conditions of chronic disease, praziquantel therapy, immunization, and Schistosoma mansoni re-encounter.
    Siddiqui AJ; Molehin AJ; Zhang W; Ganapathy PK; Kim E; Rojo JU; Redman WK; Sennoune SR; Sudduth J; Freeborn J; Hunter D; Kottapalli KR; Kottapalli P; Wettashinghe R; van Dam GJ; Corstjens PLAM; Papin JF; Carey D; Torben W; Ahmad G; Siddiqui AA
    Ann N Y Acad Sci; 2018 Aug; 1425(1):19-37. PubMed ID: 29888790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sm-p80-based schistosomiasis vaccine mediated epistatic interactions identified potential immune signatures for vaccine efficacy in mice and baboons.
    Rojo JU; Melkus MW; Kottapalli KR; Okiya OE; Sudduth J; Zhang W; Molehin AJ; Carter D; Siddiqui AA
    PLoS One; 2017; 12(2):e0171677. PubMed ID: 28192534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sm-p80-based DNA vaccine provides baboons with levels of protection against Schistosoma mansoni infection comparable to those achieved by the irradiated cercarial vaccine.
    Zhang W; Ahmad G; Torben W; Noor Z; Le L; Damian RT; Wolf RF; White GL; Chavez-Suarez M; Podesta RB; Kennedy RC; Siddiqui AA
    J Infect Dis; 2010 Apr; 201(7):1105-12. PubMed ID: 20187746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longevity of Sm-p80-specific antibody responses following vaccination with Sm-p80 vaccine in mice and baboons and transplacental transfer of Sm-p80-specific antibodies in a baboon.
    Zhang W; Ahmad G; Le L; Rojo JU; Karmakar S; Tillery KA; Torben W; Damian RT; Wolf RF; White GL; Carey DW; Carter D; Reed SG; Siddiqui AA
    Parasitol Res; 2014 Jun; 113(6):2239-50. PubMed ID: 24728521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective and antifecundity effects of Sm-p80-based DNA vaccine formulation against Schistosoma mansoni in a nonhuman primate model.
    Ahmad G; Zhang W; Torben W; Damian RT; Wolf RF; White GL; Chavez-Suarez M; Kennedy RC; Siddiqui AA
    Vaccine; 2009 May; 27(21):2830-7. PubMed ID: 19366570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preclinical prophylactic efficacy testing of Sm-p80-based vaccine in a nonhuman primate model of Schistosoma mansoni infection and immunoglobulin G and E responses to Sm-p80 in human serum samples from an area where schistosomiasis is endemic.
    Ahmad G; Zhang W; Torben W; Ahrorov A; Damian RT; Wolf RF; White GL; Carey DW; Mwinzi PN; Ganley-Leal L; Kennedy RC; Siddiqui AA
    J Infect Dis; 2011 Nov; 204(9):1437-49. PubMed ID: 21921206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the immune response to DNA vaccination strategies for schistosomiasis candidate antigen, Sm-p80 in the baboon.
    Siddiqui AA; Pinkston JR; Quinlin ML; Saeed Q; White GL; Shearer MH; Kennedy RC
    Vaccine; 2005 Feb; 23(12):1451-6. PubMed ID: 15670880
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Zhang W; Ahmad G; Molehin AJ; Torben W; Le L; Kim E; Lazarus S; Siddiqui AJ; Carter D; Siddiqui AA
    J Investig Med; 2018 Dec; 66(8):1124-1132. PubMed ID: 29997146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Schistosoma egg-induced liver pathology resolution by Sm-p80-based schistosomiasis vaccine in baboons.
    Le L; Molehin AJ; Nash S; Sennoune SR; Ahmad G; Torben W; Zhang W; Siddiqui AA
    Pathology; 2018 Jun; 50(4):442-449. PubMed ID: 29739616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective effects of Sm-p80 in the presence of resiquimod as an adjuvant against challenge infection with Schistosoma mansoni in mice.
    Ahmad G; Zhang W; Torben W; Noor Z; Siddiqui AA
    Int J Infect Dis; 2010 Sep; 14(9):e781-7. PubMed ID: 20630783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prime-boost and recombinant protein vaccination strategies using Sm-p80 protects against Schistosoma mansoni infection in the mouse model to levels previously attainable only by the irradiated cercarial vaccine.
    Ahmad G; Zhang W; Torben W; Haskins C; Diggs S; Noor Z; Le L; Siddiqui AA
    Parasitol Res; 2009 Nov; 105(6):1767-77. PubMed ID: 19809833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complement plays a minimal role in Sm-p80-mediated protection against Schistosoma mansoni.
    Karmakar S; Zhang W; Ahmad G; Alam MU; Winn R; Torben W; Le L; Tillery KA; Siddiqui AA
    Hum Vaccin Immunother; 2014; 10(3):640-7. PubMed ID: 24374377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sm-p80-based DNA vaccine formulation induces potent protective immunity against Schistosoma mansoni.
    Ahmad G; Torben W; Zhang W; Wyatt M; Siddiqui AA
    Parasite Immunol; 2009 Mar; 31(3):156-61. PubMed ID: 19222788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of antibody dependent cell mediated cytotoxicity (ADCC) in Sm-p80-mediated protection against Schistosoma mansoni.
    Torben W; Ahmad G; Zhang W; Nash S; Le L; Karmakar S; Siddiqui AA
    Vaccine; 2012 Nov; 30(48):6753-8. PubMed ID: 23000221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sm-p80-based schistosomiasis vaccine: double-blind preclinical trial in baboons demonstrates comprehensive prophylactic and parasite transmission-blocking efficacy.
    Zhang W; Molehin AJ; Rojo JU; Sudduth J; Ganapathy PK; Kim E; Siddiqui AJ; Freeborn J; Sennoune SR; May J; Lazarus S; Nguyen C; Redman WK; Ahmad G; Torben W; Karmakar S; Le L; Kottapalli KR; Kottapalli P; Wolf RF; Papin JF; Carey D; Gray SA; Bergthold JD; Damian RT; Mayer BT; Marks F; Reed SG; Carter D; Siddiqui AA
    Ann N Y Acad Sci; 2018 Aug; 1425(1):38-51. PubMed ID: 30133707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.